Evaluation of the consistence between the results of immunoinformatics predictions and real-world animal experiments of a new tuberculosis vaccine MP3RT

BackgroundOur previous study developed a novel peptide-based vaccine, MP3RT, to fight against tuberculosis (TB) infection in a mouse model. However, the consistency between the immunoinformatics predictions and the results of real-world animal experiments on the MP3RT vaccine remains unclear.MethodI...

Full description

Bibliographic Details
Main Authors: Peng Cheng, Yong Xue, Jie Wang, Zaixing Jia, Liang Wang, Wenping Gong
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-11-01
Series:Frontiers in Cellular and Infection Microbiology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcimb.2022.1047306/full
_version_ 1811255528946401280
author Peng Cheng
Peng Cheng
Yong Xue
Jie Wang
Zaixing Jia
Zaixing Jia
Liang Wang
Wenping Gong
author_facet Peng Cheng
Peng Cheng
Yong Xue
Jie Wang
Zaixing Jia
Zaixing Jia
Liang Wang
Wenping Gong
author_sort Peng Cheng
collection DOAJ
description BackgroundOur previous study developed a novel peptide-based vaccine, MP3RT, to fight against tuberculosis (TB) infection in a mouse model. However, the consistency between the immunoinformatics predictions and the results of real-world animal experiments on the MP3RT vaccine remains unclear.MethodIn this study, we predicted the antigenicity, immunogenicity, physicochemical parameters, secondary structure, and tertiary structure of MP3RT using bioinformatics technologies. The immune response properties of the MP3RT vaccine were then predicted using the C-ImmSim server. Finally, humanized mice were used to verify the characteristics of the humoral and cellular immune responses induced by the MP3RT vaccine.ResultsMP3RT is a non-toxic and non-allergenic vaccine with an antigenicity index of 0.88 and an immunogenicity index of 0.61, respectively. Our results showed that the MP3RT vaccine contained 53.36% α-helix in the secondary structure, and the favored region accounted for 98.22% in the optimized tertiary structure. The binding affinities of the MP3RT vaccine to the human leukocyte antigen (HLA)-DRB1*01:01 allele, toll-like receptor-2 (TLR-2), and TLR-4 receptors were -1234.1 kcal/mol, -1066.4 kcal/mol, and -1250.4 kcal/mol, respectively. The results of the C-ImmSim server showed that the MP3RT vaccine could stimulate T and B cells to produce immune responses, such as high levels of IgM and IgG antibodies, IFN-γ, TNF-α, and IL-2 cytokines. Results from real-world animal experiments showed that the MP3RT vaccine could stimulate the humanized mice to produce high levels of IgG and IgG2a antibodies and IFN-γ+ T lymphocytes. Furthermore, the levels of IFN-γ, IL-2, and IL-6 cytokines in mice immunized with the MP3RT vaccine were significantly higher than those in the control group.ConclusionMP3RT is a highly antigenic and immunogenic potential vaccine that can effectively induce Th1-type immune responses in silico analysis and animal experiments. This study lays the foundation for evaluating the value of computational tools and immunoinformatic techniques in reverse vaccinology research.
first_indexed 2024-04-12T17:26:11Z
format Article
id doaj.art-4a7212d811b34c29a6974808e912666e
institution Directory Open Access Journal
issn 2235-2988
language English
last_indexed 2024-04-12T17:26:11Z
publishDate 2022-11-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cellular and Infection Microbiology
spelling doaj.art-4a7212d811b34c29a6974808e912666e2022-12-22T03:23:18ZengFrontiers Media S.A.Frontiers in Cellular and Infection Microbiology2235-29882022-11-011210.3389/fcimb.2022.10473061047306Evaluation of the consistence between the results of immunoinformatics predictions and real-world animal experiments of a new tuberculosis vaccine MP3RTPeng Cheng0Peng Cheng1Yong Xue2Jie Wang3Zaixing Jia4Zaixing Jia5Liang Wang6Wenping Gong7Tuberculosis Prevention and Control Key Laboratory/Beijing Key Laboratory of New Techniques of Tuberculosis Diagnosis and Treatment, Senior Department of Tuberculosis, The 8th Medical Center of PLA General Hospital, Beijing, ChinaHebei North University, Zhangjiakou, Hebei, ChinaTuberculosis Prevention and Control Key Laboratory/Beijing Key Laboratory of New Techniques of Tuberculosis Diagnosis and Treatment, Senior Department of Tuberculosis, The 8th Medical Center of PLA General Hospital, Beijing, ChinaTuberculosis Prevention and Control Key Laboratory/Beijing Key Laboratory of New Techniques of Tuberculosis Diagnosis and Treatment, Senior Department of Tuberculosis, The 8th Medical Center of PLA General Hospital, Beijing, ChinaTuberculosis Prevention and Control Key Laboratory/Beijing Key Laboratory of New Techniques of Tuberculosis Diagnosis and Treatment, Senior Department of Tuberculosis, The 8th Medical Center of PLA General Hospital, Beijing, ChinaCangzhou Hospital of Integrated Traditional Chinese and Western Medicine, Cangzhou, Hebei, ChinaTuberculosis Prevention and Control Key Laboratory/Beijing Key Laboratory of New Techniques of Tuberculosis Diagnosis and Treatment, Senior Department of Tuberculosis, The 8th Medical Center of PLA General Hospital, Beijing, ChinaTuberculosis Prevention and Control Key Laboratory/Beijing Key Laboratory of New Techniques of Tuberculosis Diagnosis and Treatment, Senior Department of Tuberculosis, The 8th Medical Center of PLA General Hospital, Beijing, ChinaBackgroundOur previous study developed a novel peptide-based vaccine, MP3RT, to fight against tuberculosis (TB) infection in a mouse model. However, the consistency between the immunoinformatics predictions and the results of real-world animal experiments on the MP3RT vaccine remains unclear.MethodIn this study, we predicted the antigenicity, immunogenicity, physicochemical parameters, secondary structure, and tertiary structure of MP3RT using bioinformatics technologies. The immune response properties of the MP3RT vaccine were then predicted using the C-ImmSim server. Finally, humanized mice were used to verify the characteristics of the humoral and cellular immune responses induced by the MP3RT vaccine.ResultsMP3RT is a non-toxic and non-allergenic vaccine with an antigenicity index of 0.88 and an immunogenicity index of 0.61, respectively. Our results showed that the MP3RT vaccine contained 53.36% α-helix in the secondary structure, and the favored region accounted for 98.22% in the optimized tertiary structure. The binding affinities of the MP3RT vaccine to the human leukocyte antigen (HLA)-DRB1*01:01 allele, toll-like receptor-2 (TLR-2), and TLR-4 receptors were -1234.1 kcal/mol, -1066.4 kcal/mol, and -1250.4 kcal/mol, respectively. The results of the C-ImmSim server showed that the MP3RT vaccine could stimulate T and B cells to produce immune responses, such as high levels of IgM and IgG antibodies, IFN-γ, TNF-α, and IL-2 cytokines. Results from real-world animal experiments showed that the MP3RT vaccine could stimulate the humanized mice to produce high levels of IgG and IgG2a antibodies and IFN-γ+ T lymphocytes. Furthermore, the levels of IFN-γ, IL-2, and IL-6 cytokines in mice immunized with the MP3RT vaccine were significantly higher than those in the control group.ConclusionMP3RT is a highly antigenic and immunogenic potential vaccine that can effectively induce Th1-type immune responses in silico analysis and animal experiments. This study lays the foundation for evaluating the value of computational tools and immunoinformatic techniques in reverse vaccinology research.https://www.frontiersin.org/articles/10.3389/fcimb.2022.1047306/fulltuberculosis (TB)vaccineMP3RTimmune responsescomputational toolsimmunoinformatics
spellingShingle Peng Cheng
Peng Cheng
Yong Xue
Jie Wang
Zaixing Jia
Zaixing Jia
Liang Wang
Wenping Gong
Evaluation of the consistence between the results of immunoinformatics predictions and real-world animal experiments of a new tuberculosis vaccine MP3RT
Frontiers in Cellular and Infection Microbiology
tuberculosis (TB)
vaccine
MP3RT
immune responses
computational tools
immunoinformatics
title Evaluation of the consistence between the results of immunoinformatics predictions and real-world animal experiments of a new tuberculosis vaccine MP3RT
title_full Evaluation of the consistence between the results of immunoinformatics predictions and real-world animal experiments of a new tuberculosis vaccine MP3RT
title_fullStr Evaluation of the consistence between the results of immunoinformatics predictions and real-world animal experiments of a new tuberculosis vaccine MP3RT
title_full_unstemmed Evaluation of the consistence between the results of immunoinformatics predictions and real-world animal experiments of a new tuberculosis vaccine MP3RT
title_short Evaluation of the consistence between the results of immunoinformatics predictions and real-world animal experiments of a new tuberculosis vaccine MP3RT
title_sort evaluation of the consistence between the results of immunoinformatics predictions and real world animal experiments of a new tuberculosis vaccine mp3rt
topic tuberculosis (TB)
vaccine
MP3RT
immune responses
computational tools
immunoinformatics
url https://www.frontiersin.org/articles/10.3389/fcimb.2022.1047306/full
work_keys_str_mv AT pengcheng evaluationoftheconsistencebetweentheresultsofimmunoinformaticspredictionsandrealworldanimalexperimentsofanewtuberculosisvaccinemp3rt
AT pengcheng evaluationoftheconsistencebetweentheresultsofimmunoinformaticspredictionsandrealworldanimalexperimentsofanewtuberculosisvaccinemp3rt
AT yongxue evaluationoftheconsistencebetweentheresultsofimmunoinformaticspredictionsandrealworldanimalexperimentsofanewtuberculosisvaccinemp3rt
AT jiewang evaluationoftheconsistencebetweentheresultsofimmunoinformaticspredictionsandrealworldanimalexperimentsofanewtuberculosisvaccinemp3rt
AT zaixingjia evaluationoftheconsistencebetweentheresultsofimmunoinformaticspredictionsandrealworldanimalexperimentsofanewtuberculosisvaccinemp3rt
AT zaixingjia evaluationoftheconsistencebetweentheresultsofimmunoinformaticspredictionsandrealworldanimalexperimentsofanewtuberculosisvaccinemp3rt
AT liangwang evaluationoftheconsistencebetweentheresultsofimmunoinformaticspredictionsandrealworldanimalexperimentsofanewtuberculosisvaccinemp3rt
AT wenpinggong evaluationoftheconsistencebetweentheresultsofimmunoinformaticspredictionsandrealworldanimalexperimentsofanewtuberculosisvaccinemp3rt